Skip to Content

Raltegravir

In the US, Raltegravir (raltegravir systemic) is a member of the drug class integrase strand transfer inhibitor and is used to treat HIV Infection and Occupational Exposure.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AX08

CAS registry number (Chemical Abstracts Service)

0518048-05-0

Chemical Formula

C20-H21-F-N6-O5

Molecular Weight

444

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV integrase inhibitor

Chemical Names

N-[(4-Fluorophenyl)metyl]-5-hydroxy-1-metyl-2-[2-(5-metyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide (WHO)

4-Pyrimidinecarboxamide, N-((4-fluorophenyl)metyl)-1,6-dihydro-5-hydroxy-1-metyl-2-(1-metyl-1-(((5-metyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)etyl)-6-oxo-

5-Hydroxy-1-metyl-2-{1-metyl-1-[(5-metyl[1,3,4]oxadiazol-2-carbonyl)amino]etyl}-6-oxo-1,6-dihydropyrimidin-4-carbonsäure-4-fluorbenzylamid (IUPAC)

N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-metyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-metyl-1,3,4-oxadiazole-2-carboxamide

Foreign Names

  • Raltegravirum (Latin)
  • Raltegravir (German)
  • Raltégravir (French)
  • Raltegravir (Spanish)

Generic Names

  • Raltegravir (OS: BAN)
  • c-1605 (IS)
  • MK-0518 (IS)
  • MK-518 (IS: Merck)
  • Raltegravir Potassium (OS: USAN, BANM, JAN)
  • 4-Pyrimidinecarboxamide (IS)

Brand Names

  • Isentress
    Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Slovakia; Merck Sharp & Dohme, Taiwan; MSD, Costa Rica; MSD, Denmark; MSD, Dominican Republic; MSD, Guatemala; MSD, Honduras; MSD, Nicaragua; MSD, Netherlands; MSD, Panama; MSD, El Salvador; MSD, Thailand; MSD, South Africa; MSD Belgium, Belgium
  • Dutrebis (Raltegravir and Lamivudine)
    Merck Sharp & Dohme, United States
  • Isentress
    Merck, Canada; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, Czech Republic; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Georgia; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Israel; Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Serbia; Merck Sharp & Dohme, United States; MSD, Argentina; MSD, Switzerland; MSD, China; MSD, Finland; MSD, Ireland; MSD, Japan; MSD, Norway; MSD, Sweden; MSD France, France; MSD Italia, Italy; MSD Pharma, Hungary
  • ISENTRESS
    Merck Sharp & Dohme, Latvia; MSD Merck Sharp & Dohme, Germany
  • Isentress Suspension
    Merck Sharp & Dohme, United Kingdom

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide